Breaking News Instant updates and real-time market news.

ALSN

Allison Transmission

$35.37

0.11 (0.31%)

, ETN

Eaton

$72.54

0.55 (0.76%)

04:55
03/23/17
03/23
04:55
03/23/17
04:55

Bofa/Merrill to hold a conference

Global Industrials & EU Autos Conference is being held in London, England on March 21-23.

ALSN

Allison Transmission

$35.37

0.11 (0.31%)

ETN

Eaton

$72.54

0.55 (0.76%)

URI

United Rentals

$120.38

0.37 (0.31%)

ROK

Rockwell Automation

$154.61

0.46 (0.30%)

TKR

Timken

$44.00

0.85 (1.97%)

AGCO

Agco

$59.89

0.3 (0.50%)

KMT

Kennametal

$37.13

-0.25 (-0.67%)

FTV

Fortive

$58.49

-0.02 (-0.03%)

DOV

Dover

$77.97

-0.32 (-0.41%)

RXN

Rexnord

$23.32

-0.19 (-0.81%)

  • 23

    Mar

  • 11

    May

ALSN Allison Transmission
$35.37

0.11 (0.31%)

02/16/17
PIPR
02/16/17
NO CHANGE
Target $30
PIPR
Underweight
Piper says use recent rally to sell Allison Transmission
Piper Jaffray analyst Alexander Potter reiterates an Underweight rating and $30 price target on shares of Allison Transmission after meeting with California-based electric bus maker Proterra. The company has built a one year-plus backlog and is in the process of aggressively ramping production, Potter tells investors in a research note. He believes that investors become aware of Proterra's success in electrifying municipal buses, they will realize that most specialty/urban vehicle applications are susceptible to disruption by electric vehicles. This trend "will eventually spell trouble" for Allison Transmission, since 70% of the company's revenue comes from on-highway market, the analyst contends. He recommends using the recent rally to sell Allison shares.
02/26/17
GSCO
02/26/17
DOWNGRADE
Target $41
GSCO
Neutral
Allison Transmission downgraded to Neutral from Buy at Goldman
Goldman Sachs analyst Jerry Revich downgraded Allison Transmission (ALSN) to Neutral from Buy with an unchanged price target of $41. The manufacturer of fully-automatic transmissions for trucks closed Friday up 24c to $36.79. The stock, currently trading at an 8% free cash flow yield versus 13% in Sept. 2013, offers limited upside and a balanced risk/reward profile, Revich tells investors in a research note. He also believes that the range of competitive transmission options is rising. Ford (F) is gaining share with its automotive engine and transmission, Revich points out.
03/03/17
JPMS
03/03/17
NO CHANGE
JPMS
February Class 8 orders up 28% to highest level in over a year, says JPMorgan
JPMorgan analyst Ann Duignan noted that ACT Research reported Class 8 truck orders were up 28% in February to 23,200 units, which represents the highest reading in 14 months. However, she notes that truck-related stocks outperformed the broader market in 2016 and are up 11% year-to-date, leaving her to believe that much of the upside from an improvement in orders is already priced in. Stocks that may respond to truck orders include Navistar (NAV), PACCAR (PCAR), Cummins (CMI) and Allison Transmission (ALSN).
02/03/17
WELS
02/03/17
NO CHANGE
WELS
Class 8 truck orders 'modestly' above expectations in January, says Wells Fargo
Stocks that may respond to truck orders include Navistar (NAV), PACCAR (PCAR), Cummins (CMI) and Allison Transmission (ALSN).
ETN Eaton
$72.54

0.55 (0.76%)

01/03/17
VERT
01/03/17
DOWNGRADE
VERT
Hold
Eaton downgraded to Hold from Buy at Vertical Research
02/03/17
JPMS
02/03/17
DOWNGRADE
Target $70
JPMS
Neutral
Eaton downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Ann Duignan downgraded Eaton to Neutral saying "broad weakness" across end markets will limit upside to 2017 earnings. The analyst lowered her price target for the shares to $70 from $75 following the company's Q4 results.
01/09/17
BOFA
01/09/17
UPGRADE
Target $78
BOFA
Buy
Eaton upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Andrew Obin upgraded Eaton to Buy and raised its price target to $78 from $66. The analyst believes Eaton's valuation is attractive given expectations for a cyclical acceleration in organic revenue following tow years of restructuring and strong operating leverage. He believes Eaton's attractive 3%+ dividend yield provides downside protection to shares.
12/09/16
12/09/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AstraZeneca (AZN) upgraded to Outperform from Market Perform at Leerink with analyst Seamus Fernandez saying the recent weakness in shares provides an "excellent entry point" ahead of several critical pipeline events that have the potential "to transform this giant into an exciting growth story." 2. Autodesk (ADSK) upgraded to Buy from Hold at Canaccord with analyst Richard Davis citing expectations for improved free cash flow, as he sees a path to $6 in FCF by 2020 and $11 per share in 2022. 3. Eaton (ENT) upgraded to Overweight from Neutral at JPMorgan with analyst Ann Duignan saying optionality of the company's balance sheet should offset broad weakness across its end markets. 4. Fluor (FLR) upgraded to Buy from Neutral at Citi with analyst Andrew Kaplowitz saying the company is positioned to outperform given amid oil and gas capex stabilization, a lift off the bottom in mining off the bottom and "muted" 2017 expectations. 5. Sysco (SYY) upgraded to Neutral from Sell at Goldman. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
URI United Rentals
$120.38

0.37 (0.31%)

03/15/17
03/15/17
UPGRADE
Target $20

Buy
Neff double upgraded to Buy on improving pricing, free cash flow at BofA/Merrill
As previously reported, BofA Merrill Lynch analyst Ross Gilardi upgraded Neff (NEFF) by two notches, to Buy from Underperform, and raised his price target on the shares to $20 from $12. The analyst said the read-across on rental from CONEXPO was positive, pricing in the rental market is improving, state fiscal stimulus measures are supportive in the Sunbelt region and that the company's free cash flow generation is reassuring. Gilardi also noted that Neff shares have lagged industry leader United Rentals (URI) year-to-date and thinks his new target, which is an 11% discount to his target for United Rentals, "seems justified."
02/02/17
ARGS
02/02/17
DOWNGRADE
ARGS
Hold
United Rentals downgraded on valuation at Argus
As noted earlier, Argus downgraded United Rentals to Hold from Buy. Analysts Stephen Biggar and Deborah Ciervo downgraded the stock based on valuation.
02/02/17
ARGS
02/02/17
DOWNGRADE
ARGS
Hold
United Rentals downgraded to Hold from Buy at Argus
01/26/17
01/26/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. United Rentals (URI) upgraded to Outperform from Market Perform at Avondale with analyst Lawrence Pfeffer saying he believes the acquisition of NES Rentals provides URI with increased means to meet or exceed expectations and provides several levers to drive EBITDA growth independent of the cycle. 2. Estee Lauder (EL) upgraded to Outperform from Perform at Oppenheimer with analyst Rupesh Parikh saying the company is better positioned for growth following recent acquisitions in the makeup category and more aggressive partnerships. 3. Grainger (GWW) upgraded to Hold from Sell at Deutsche Bank with analyst John Inch saying the company's distributor positioning is likely to continue to be favorably viewed by the market. The analyst raised his price target for the shares to $246 from $194 following the company's fourth quarter results. 4. Clovis (CLVS) upgraded to Overweight from Neutral at Piper Jaffray with analyst Steven Breazzano saying he has confidence in the total market potential for PARP inhibitors and expects them to "supplant platinum therapy well beyond ovarian or breast cancer and define new combinations broadly in oncology." 5. RPC, Inc. (RES) upgraded to Outperform from Neutral at Credit Suisse and to Buy from Neutral at Guggenheim. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
ROK Rockwell Automation
$154.61

0.46 (0.30%)

01/27/17
GABE
01/27/17
DOWNGRADE
GABE
Sell
Rockwell Automation downgraded to Sell from Hold at Gabelli
Gabelli analyst Justin Bergner downgraded Rockwell to Sell following the the strong Q1 report citing valuation.
01/26/17
FBCO
01/26/17
NO CHANGE
Target $145
FBCO
Neutral
Rockwell Automation price target raised to $145 from $121 at Credit Suisse
Credit Suisse analyst Julian Mitchell raised his price target for Rockwell Automation to $145 from $121 following a "very strong" performance from the company in Q1. Nonetheless, the analyst believes that the magnitude of the EPS beat for the December quarter is unlikely to be repeated in the coming quarters. He reiterates a Neutral rating on the shares.
01/09/17
01/09/17
UPGRADE
Target $145

Equal Weight
Rockwell Automation upgraded to Equal Weight on IP cycle at Morgan Stanley
As previously reported, Morgan Stanley upgraded Rockwell Automation to Equal Weight from Underweight and raised its price target to $145 from $136. Analyst Nigel Coe sees upside to estimates from an accelerating US IP cycle and views valuation as reasonable.
01/20/17
BUCK
01/20/17
UPGRADE
Target $162
BUCK
Buy
Rockwell Automation upgraded to Buy from Neutral at Buckingham
Buckingham upgraded Rockwell Automation to Buy with a $162 price target saying it fits a recovery thesis better than most and risk/reward is attractive. The firm's analyst said, after declines in U.S. capex spending for the past 4 years, Rockwell has meaningful operating leverage in what appears to be a budding improvement, optionality on policy initiatives, including energy deregulation, factory growth, offshore cash, and remains a takeout "threat."
TKR Timken
$44.00

0.85 (1.97%)

11/17/16
BOFA
11/17/16
DOWNGRADE
BOFA
Neutral
Timken downgraded to Neutral from Buy at BofA/Merrill
11/17/16
11/17/16
DOWNGRADE
Target $40

Neutral
Timken downgraded to Neutral on valuation at BofA/Merrill
As previously reported, BofA/Merrill downgraded Timken to Neutral from Buy and raised its price target to $40 from $35. Analyst Ross Gilardi said shares are up sharply with the group on expectations of fiscal stimulus and China acceleration but said a rising US fiscal deficit, higher interest rates, and a stronger US dollar are generally not a positive for Timken's end markets of commodities and emerging markets.
12/08/16
STFL
12/08/16
DOWNGRADE
Target $42
STFL
Hold
Timken downgraded to Hold from Buy at Stifel
Stifel analyst Stanley Elliott downgraded Timken to Hold and raised its price target to $42 from $37 citing recent share strength.
01/27/17
GSCO
01/27/17
UPGRADE
Target $55
GSCO
Conviction Buy
Timken upgraded to Conviction Buy from Neutral at Goldman
Goldman analyst Joe Ritchie upgraded Timken to Conviction Buy with a $55 price target. The analyst believes Timken is positioned to benefit from accelerating industrial demand combined with improving short-cycle/distributor data points. He expects organic growth to inflect in Q2, grow normalized earnings 46% cycle-on-cycle, and said it one of the better cash generators in his SMID coverage.
AGCO Agco
$59.89

0.3 (0.50%)

01/06/17
VERT
01/06/17
DOWNGRADE
VERT
Sell
AGCO downgraded to Sell from Hold at Vertical Research
01/24/17
BREN
01/24/17
INITIATION
Target $72
BREN
Buy
AGCO initiated with a Buy at Berenberg
Berenberg analyst Sebastian Juenne initiated AGCO with a Buy and a $72 price target saying he likes its balanced geographical exposure and expects 2016 to be a trough year. The analyst said weakness in North America should be offset by a strong business in South America and a stable Europe.
01/24/17
01/24/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Deere (DE) initiated with a Sell at Berenberg, while the firm initiated AGCO (AGCO) with a Buy. 2. Douglas Dynamics (PLOW) initiated with a Buy at Craig-Hallum. 3. DCP Midstream (DCP) initiated with an Underweight at Morgan Stanley. 4. TechnipFMC (FTI) initiated with a Buy at Goldman. 5. FS Investment (FSIC) initiated with a Neutral at Janney Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/18/17
OTRG
01/18/17
NO CHANGE
OTRG
North American Farm Equipment sector upgraded to Mixed at OTR Global
OTR Global upgraded the North American Farm Equipment sector to Mixed following positive dealer checks that indicates farm income is better than expected. The firm's analyst now expects 2017 sales to be down 1-4% year-over-year, versus October forecast of down 3-6%.
KMT Kennametal
$37.13

-0.25 (-0.67%)

02/03/17
JPMS
02/03/17
UPGRADE
Target $36
JPMS
Neutral
Kennametal upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Ann Duignan upgraded Kennametal to Neutral saying the company's Q2 results indicate its sales have inflected. Kennametal reported its first positive organic sales growth in more than two years, Duignan tells investors in a post-earnings research note. She raised her price target for the shares to $36 from $27.
02/03/17
GHSC
02/03/17
UPGRADE
Target $50
GHSC
Buy
Kennametal upgraded to Buy from Neutral at Seaport Global
Seaport Global analyst Walt Liptak raised Kennametal to Buy with a $50 price target citing and improving end market recovery, cost reduction benefits, related operating leverage and management's ability to maintain low cost levels during the upturn.
01/13/17
01/13/17
UPGRADE
Target $36

Neutral
Kennametal upgraded to Neutral on demand recovery at BofA/Merrill
As previously reported, BofA/Merrill upgraded Kennametal to Neutral from Underperform and raised its price target to $36 from $21. Analyst Ross Gilardi still sees risk to FY17 but said distributor demand started to improve in late 2016 and margins are far below the prior peak.
03/01/17
LBOW
03/01/17
UPGRADE
LBOW
Neutral
Kennametal upgraded to Neutral from Underperform at Longbow
FTV Fortive
$58.49

-0.02 (-0.03%)

01/18/17
01/18/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. AutoZone (AZO) and O'Reilly Automotive (ORLY) were initiated with a Buy at Guggenheim, while the firm initiated Advance Auto Parts (AAP) with a Neutral. 2 Kansas City Southern (KSU) was initiated with a Buy at Buckingham, while the firm initiated Norfolk Southern (NSC) and Union Pacific (UNP) with a Neutral. 3. Fortive (FTV) initiated with a Perform at Oppenheimer. 4. Halliburton (HAL) was initiated with a Buy at SunTrust, while the firm initiated Helmerich & Payne (HP) with a Sell. The firm also initiated Baker Hughes (BHI) and Schlumberger (SLB) with a Hold. 5. Expedia (EXPE) was initiated with a Strong Buy at Miller Tabak, while the firm initiated Priceline (PCLN) with a Buy and TripAdvisor (TRIP) with a Hold. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/13/17
FBCO
01/13/17
UPGRADE
FBCO
Outperform
Fortive upgraded to Outperform from Neutral at Credit Suisse
01/17/17
OPCO
01/17/17
INITIATION
OPCO
Perform
Fortive initiated with a Perform at Oppenheimer
Oppenheimer analyst Jim Giannakouros initiated Fortive with a Perform rating.
01/13/17
FBCO
01/13/17
UPGRADE
Target $60
FBCO
Outperform
Fortive upgraded to Outperform on valuation, M&A catalysts at Credit Suisse
As previously reported, Credit Suisse upgraded Fortive to Outperform from Neutral and raised its price target to $60 from $54. Analyst Julian Mitchell thinks recent underperformance has created an attractive entry point and views shares as an underappreciated way of playing a short-cycle industrial recovery as well as potential benefits from the incoming Administration. Mitchell expects M&A activity to pick up materially in 2017, which should prove to be a meaningful catalysts for the shares.
DOV Dover
$77.97

-0.32 (-0.41%)

01/03/17
BOFA
01/03/17
NO CHANGE
BOFA
BofA/Merrill's Top 10 Q1 Ideas
BofA/Merrill Strategy group named its Top 10 US ideas for Q1 2017. The selections are more heavily weighted towards companies that will benefit from increased fiscal stimulus, a pro-business agenda, and tax reform. They are Buy rated Aetna (AET), Dover (DOV), General Dynamics (GD), Hess Corp. (HES), MGM Resorts (MGM), Norfolk Southern (NSC), SVB Financial (SIVB), and Texas Instruments (TXN), and Underperform rated Consolidated Edison (ED) and TripAdvisor (TRIP).
02/22/17
BMOC
02/22/17
INITIATION
Target $82
BMOC
Market Perform
Dover initiated with a Market Perform at BMO Capital
BMO Capital analyst Scott Graham initiated Dover with a Market Perform and an $82 price target.
01/03/17
VERT
01/03/17
UPGRADE
VERT
Buy
Dover upgraded to Buy from Hold at Vertical Research
01/06/17
UBSW
01/06/17
UPGRADE
Target $90
UBSW
Buy
Dover upgraded to Buy from Sell at UBS
UBS analyst Shannon O'Callaghan double upgraded Dover to Buy from Sell saying the company's Energy business should see a "sharp recovery" in 2017-2018 as U.S. rig counts rise and margins improve. The analyst believes current estimates for Dover Energy could prove conservative. O'Callaghan upped the stock's price target to $90 from $65.
RXN Rexnord
$23.32

-0.19 (-0.81%)

06/23/16
BARD
06/23/16
DOWNGRADE
BARD
Neutral
Rexnord downgraded to Neutral from Outperform at Baird
11/08/16
BARD
11/08/16
UPGRADE
Target $21
BARD
Outperform
Rexnord upgraded to Outperform from Neutral at Baird
Baird analyst Mig Dobre upgraded Rexnord to Outperform from Neutral following management's presentation of its growth plans over the next 3-5 years while acknowledging difficult end-market conditions over the past three years. The analyst noted shares have lagged and with lowered expectations and valuation and a sound long-term strategy, he sees opportunity at current levels. Dobre has a $21 price target on Rexnord shares.
12/27/16
BARD
12/27/16
NO CHANGE
Target $23
BARD
Outperform
Rexnord relatively inexpensive industrial laggard idea for 2017, says Baird
Baird analyst Mig Dobre said investors should look at Rexnord as an investment idea for 2017, calling it a relatively inexpensive industrial laggard. The analyst believes guidance is achievable and potentially conservative and said its delivering should help the story. Dobre reiterated his Outperform rating and $23 price target on Rexnord shares.
10/24/16
LEHM
10/24/16
UPGRADE
Target $26
LEHM
Overweight
Rexnord upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Scott Davis upgraded Rexnord to Overweight after raising the U.S. Multi-Industry sector to Positive from Neutral. The negative earnings revision cycle is nearing an end and the recent pullback in the shares has created an attractive entry point, Davis tells investors in a research note. He raised his price target for Rexnord to $26 from $20.

TODAY'S FREE FLY STORIES

WAC

Walter Investment

$0.51

-0.0056 (-1.09%)

10:24
10/21/17
10/21
10:24
10/21/17
10:24
Hot Stocks
Walter Investment reaches agreement on financial restructuring »

Walter Investment has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMST

TimkenSteel

$17.57

0.19 (1.09%)

10:18
10/21/17
10/21
10:18
10/21/17
10:18
Hot Stocks
Tentative agreement between TimkenSteel, United Steelworkers voted down »

TimkenSteel employees who…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

AGEN

Agenus

$4.33

-0.14 (-3.13%)

, GSK

GlaxoSmithKline

$40.84

-0.26 (-0.63%)

10:15
10/21/17
10/21
10:15
10/21/17
10:15
Hot Stocks
FDA approves GlaxoSmithKline shingles vaccine with Agenus QS-21 Stimulon »

Agenus (AGEN) has…

AGEN

Agenus

$4.33

-0.14 (-3.13%)

GSK

GlaxoSmithKline

$40.84

-0.26 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 06

    Nov

MS

Morgan Stanley

$50.68

0.89 (1.79%)

10:06
10/21/17
10/21
10:06
10/21/17
10:06
Periodicals
Another 20% gain in Morgan Stanley stock likely, Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

SSNLF

Samsung

10:02
10/21/17
10/21
10:02
10/21/17
10:02
Periodicals
Samsung has lots of upside driven by chips/screens, Barron's says »

Samsung stock is up 50%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 30

    Oct

DLAKY

Lufthansa

$30.28

0.2 (0.66%)

09:56
10/21/17
10/21
09:56
10/21/17
09:56
Periodicals
Lufthansa has more room to climb, Barron's says »

Amid competitor's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$59.90

0.12 (0.20%)

, DAL

Delta Air Lines

$53.27

1 (1.91%)

09:51
10/21/17
10/21
09:51
10/21/17
09:51
Periodicals
Market pounds United, sees American/Delta as possibly safe bets, Barron's says »

United Continental's…

UAL

United Continental

$59.90

0.12 (0.20%)

DAL

Delta Air Lines

$53.27

1 (1.91%)

AAL

American Airlines

$51.93

0.42 (0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 26

    Oct

  • 01

    Nov

CZR

Caesars

$12.20

0.15 (1.24%)

09:45
10/21/17
10/21
09:45
10/21/17
09:45
Periodicals
Caesars looks ready to grow again, Barron's says »

After a disastrous 2008…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 08

    Nov

DWDP

DowDuPont

$71.18

0.29 (0.41%)

09:40
10/21/17
10/21
09:40
10/21/17
09:40
Periodicals
DowDuPont shares likely to return as much as 30% over next year, Barron's says »

If DowDuPont can cut $3B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COH

Coach

$40.35

0.88 (2.23%)

09:29
10/21/17
10/21
09:29
10/21/17
09:29
Periodicals
Coach shares look undervalued, could rise nearly 30%, Barron's says »

Coach, which has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$96.50

1.8 (1.90%)

, MOH

Molina Healthcare

$64.40

0.76 (1.19%)

09:24
10/21/17
10/21
09:24
10/21/17
09:24
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

CNC

Centene

$96.50

1.8 (1.90%)

MOH

Molina Healthcare

$64.40

0.76 (1.19%)

CI

Cigna

$191.42

3.2 (1.70%)

ANTM

Anthem

$194.69

1.49 (0.77%)

AET

Aetna

$160.84

3.2 (2.03%)

HNT

Health Net

HUM

Humana

$245.81

3.12 (1.29%)

UNH

UnitedHealth

$207.49

4.24 (2.09%)

WCG

WellCare

$180.52

3.28 (1.85%)

CYH

Community Health

$6.44

0.24 (3.87%)

HCA

HCA Healthcare

$81.05

1.26 (1.58%)

LPNT

LifePoint

$58.35

0.5 (0.86%)

THC

Tenet

$14.66

1.31 (9.81%)

UHS

Universal Health

$112.85

2.31 (2.09%)

GOOG

Alphabet

$988.20

3.75 (0.38%)

GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

MSFT

Microsoft

$78.81

0.9 (1.16%)

FB

Facebook

$174.98

0.42 (0.24%)

INTC

Intel

$40.43

0.34 (0.85%)

IBM

IBM

$162.07

1.17 (0.73%)

MAR

Marriott

$115.02

-0.18 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 31

    Oct

  • 31

    Oct

  • 01

    Nov

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 02

    Nov

  • 02

    Nov

  • 03

    Nov

  • 06

    Nov

  • 08

    Nov

  • 08

    Nov

  • 08

    Nov

  • 15

    Nov

  • 15

    Nov

  • 29

    Nov

  • 30

    Nov

  • 18

    Mar

ETFC

E-Trade

$43.20

-0.49 (-1.12%)

08:55
10/21/17
10/21
08:55
10/21/17
08:55
Conference/Events
E-Trade to hold an education day »

Chicago Education Day is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 07

    Nov

08:45
10/21/17
10/21
08:45
10/21/17
08:45
General news
Breaking General news story  »

New York Federal Reserve…

FB

Facebook

$174.98

0.42 (0.24%)

, AMZN

Amazon.com

$982.91

-3.7 (-0.38%)

08:25
10/21/17
10/21
08:25
10/21/17
08:25
Periodicals
Regulators inquiries fuel speculation about big tech breakup, Barron's says »

Facebook (FB), Amazon…

FB

Facebook

$174.98

0.42 (0.24%)

AMZN

Amazon.com

$982.91

-3.7 (-0.38%)

GOOG

Alphabet

$988.20

3.75 (0.38%)

GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 26

    Oct

  • 26

    Oct

  • 01

    Nov

  • 08

    Nov

  • 15

    Nov

  • 29

    Nov

  • 18

    Mar

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

, AIMT

Aimmune

$25.66

-0.06 (-0.23%)

07:58
10/21/17
10/21
07:58
10/21/17
07:58
Hot Stocks
DBV believes FDA suggested continue moving forward with Viaskin »

DBV Technologies (DBVT)…

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

AIMT

Aimmune

$25.66

-0.06 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

04:55
10/21/17
10/21
04:55
10/21/17
04:55
General news
Breaking General news story  »

New York Federal Reserve…

ETFC

E-Trade

$43.20

-0.49 (-1.12%)

04:55
10/21/17
10/21
04:55
10/21/17
04:55
Conference/Events
E-Trade to hold an education day »

Chicago Education Day is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 07

    Nov

19:15
10/20/17
10/20
19:15
10/20/17
19:15
General news
Breaking General news story  »

Federal Reserve Chair…

ATRS

Antares Pharma

$2.18

0.06 (2.83%)

18:59
10/20/17
10/20
18:59
10/20/17
18:59
Hot Stocks
FDA cannot approve Antares Pharma's Xyosted NDA »

Antares Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

18:55
10/20/17
10/20
18:55
10/20/17
18:55
Conference/Events
Federal Reserve Chairperson delivers a lecture at NEC Dinner »

Federal Reserve…

SHIP

Seanergy Marine

$1.24

0.0199 (1.63%)

17:50
10/20/17
10/20
17:50
10/20/17
17:50
Syndicate
Breaking Syndicate news story on Seanergy Marine »

Seanergy Marine files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLI

Houlihan Lokey

$41.56

0.18 (0.43%)

17:49
10/20/17
10/20
17:49
10/20/17
17:49
Syndicate
Breaking Syndicate news story on Houlihan Lokey »

Houlihan Lokey files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

GEO

Geo Group

$26.20

0.2 (0.77%)

17:48
10/20/17
10/20
17:48
10/20/17
17:48
Syndicate
Breaking Syndicate news story on Geo Group »

Geo Group files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

, AIMT

Aimmune

$25.66

-0.06 (-0.23%)

17:37
10/20/17
10/20
17:37
10/20/17
17:37
Hot Stocks
DBV sinks following peanut allergy trial miss, Aimmune soars »

Shares of DBV…

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

AIMT

Aimmune

$25.66

-0.06 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

KALV

KalVista

$11.26

1.99 (21.47%)

, DBVT

DBV Technologies

$48.07

0.92 (1.95%)

17:24
10/20/17
10/20
17:24
10/20/17
17:24
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: KalVista (KALV),…

KALV

KalVista

$11.26

1.99 (21.47%)

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.